ACTIVE

NEWPHARMA GROUP

Export PDF

Financial year 2026 · Closed on 31/03/2026

Net result123,7 k €+392,7 %over 1 year

Revenue60,9 M €+684,0 %over 1 year

Equity86,8 M €+0,2 %over 1 year

Workforce100,9 ETP+157,4 %over 1 year

Identity

Source · BCE/KBO

NEWPHARMA GROUP is a Public limited company incorporated in 2017. Its main activity is: Activities of head offices. Its registered office is in Liège. It employs on average 100,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0684.465.652
Incorporation: 07/11/2017
Legal form: Public limited company
Registered office: Rue du Charbonnage 9
4020 Liège · WallonieSee on map
Contributed capital: 86 745 274,00 €
Latest accounts: 31/03/2026
Average workforce: 100,9 ETP

Activities (NACE)

70100Activities of head offices· main 70100Activities of head offices 70200Management consultancy activities 70220Business and other management consultancy activities

Joint committees (1)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 12 filings

Trend over 8 financial years

	2026		2025		2024		2022		2021
Income statement
Revenue	60,9 M €	+684%	7,8 M €	-6.9%	8,4 M €	+114%	3,9 M €	-5.5%	4,1 M €
EBITDA	3,5 M €	+696%	437,3 k €	+1359%	30 k €	+102%	-1,4 M €	-478%	-242,3 k €
Operating result	592,7 k €	+406%	117,2 k €	+120%	-599,1 k €	+68.4%	-1,9 M €	-394%	-383,9 k €
Net result	123,7 k €	+393%	-42,3 k €	+96.6%	-1,2 M €	+48.2%	-2,4 M €	-228%	-726,8 k €
Balance sheet
Equity	86,8 M €	+0.2%	86,7 M €	+8.7%	79,7 M €	+30.8%	61 M €	-3.8%	63,4 M €
Total assets	109,2 M €	+8.0%	101,1 M €	+1.9%	99,2 M €	+3.4%	96 M €	+8.7%	88,3 M €
Cash	21,5 k €	+1673%	1,2 k €	-96.7%	36,7 k €	+326%	8,6 k €	-89.8%	84 k €
Debts	22,1 M €	+57.2%	14,1 M €	-25.9%	19 M €	-44.9%	34,5 M €	+40.2%	24,6 M €
Other
Workforce	100,9 ETP	+157%	39,2 ETP	-6.4%	41,9 ETP	+5.8%	39,6 ETP	+10.0%	36,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/03/2026

7 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
MICHAEL HAMELRIJCK	Directorsince 01/08/2026
JEF COLRUYT	Director20/01/2023 → 22/06/2029
JO WILLEMYNS	Director20/01/2023 → 22/06/2029
KRIS CASTELEIN	Director20/01/2023 → 22/06/2029
STEFAAN VANDAMME	Director20/01/2023 → 22/06/2029
STEFAN GOETHAERT	Director20/01/2023 → 22/06/2029
GJ LIFESCIENCES MANAGEMENT0770.962.631Represented by GILLES JOURQUIN	Managing director14/07/2021 → 25/06/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Colruyt Group0400.378.485Represented by STEFAAN VANDAMME	Director25/08/2021 → 2021 accounts
KORYS BUSINESS SERVICES I NV0418.759.787Represented by DRIES COLPAERT	Director25/08/2021 → 2021 accounts
Korys Business Services II NV0450.623.396Represented by DRIES CREVITS	Director25/08/2021 → 2021 accounts
LISA COLRUYT	Director25/08/2021 → 2021 accounts

Other companies at this address

Rue du Charbonnage 9 4020 Liège

Company	CBE no.
Pranelya● Active	1044.263.297
Smartvalue Distribution● Active	1004.124.303

Full financial information

Source · NBB

	2026	2025	2024	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/04/2025	01/04/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/03/2026	31/03/2025	31/03/2024	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	15 months	12 months	12 months	12 months
Filing date	21/10/2026	25/09/2025	19/09/2024	05/07/2023	06/07/2022	28/07/2021
General meeting	19/10/2026	16/09/2025	17/09/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings

Model	Closing	General meeting	Filed	Language	Document
Full modelCorrection	31/03/2026	19/10/2026	21/10/2026	French	PDF
Full model	31/03/2026	15/09/2026	21/09/2026	French	PDF
Full model	31/03/2025	16/09/2025	25/09/2025	French	PDF
Full model	31/03/2024	17/09/2024	19/09/2024	French	PDF
Full model	31/12/2022	30/06/2023	05/07/2023	French	PDF
Full model	31/12/2021	30/06/2022	06/07/2022	French	PDF
Consolidated accounts	31/12/2021	30/06/2022	06/07/2022	French	PDF
Full model	31/12/2020	30/06/2021	28/07/2021	French	PDF
Consolidated accounts	31/12/2020	30/06/2021	26/07/2021	French	PDF
Full model	31/12/2019	30/07/2020	14/08/2020	French	PDF
Consolidated accounts	31/12/2019	30/07/2020	14/08/2020	French	PDF
Full model	31/12/2018	28/06/2019	25/07/2019	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2026

7 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
MICHAEL HAMELRIJCK	Directorsince 01/08/2026
JEF COLRUYT	Director20/01/2023 → 22/06/2029
JO WILLEMYNS	Director20/01/2023 → 22/06/2029
KRIS CASTELEIN	Director20/01/2023 → 22/06/2029
STEFAAN VANDAMME	Director20/01/2023 → 22/06/2029
STEFAN GOETHAERT	Director20/01/2023 → 22/06/2029
GJ LIFESCIENCES MANAGEMENT0770.962.631Represented by GILLES JOURQUIN	Managing director14/07/2021 → 25/06/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Colruyt Group0400.378.485Represented by STEFAAN VANDAMME	Director25/08/2021 → 2021 accounts
KORYS BUSINESS SERVICES I NV0418.759.787Represented by DRIES COLPAERT	Director25/08/2021 → 2021 accounts
Korys Business Services II NV0450.623.396Represented by DRIES CREVITS	Director25/08/2021 → 2021 accounts
LISA COLRUYT	Director25/08/2021 → 2021 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office29/06/2026
SIEGE SOCIAL
PDF
Restructuring20/11/2025
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring04/09/2025
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Capital / shares04/04/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Other14/06/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Mandates20/10/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares07/04/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates23/03/2023
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings8 filings

Mandates

MICHAEL HAMELRIJCK

KRIS CASTELEIN

STEFAAN VANDAMME

JEF COLRUYT

JO WILLEMYNS

STEFAN GOETHAERT

GJ LIFESCIENCES MANAGEMENT

Colruyt Group

KORYS BUSINESS SERVICES I NV

Korys Business Services II NV

LISA COLRUYT

ORGANISATION - MANAGEMENT- CONSULTANCY and RELATIONS

Show the 2 other mandates

201720182019202020212022202320242025202620272028

NEWPHARMA GROUP

Rue du Charbonnage 10 bte 2, 4020 Liège-4020

Director

Managing director

Director

Chairman of the board of directors

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue du Charbonnage 9, 4020 Liège-4020Current	accounts 2026	Accounts 2026 · 2026-00568687
Rue du Charbonnage 10 bte 2, 4020 Liège-4020	accounts 2021 → 2025	Accounts 2025 · 2025-00505520

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
NEWPHARMA GROUPCurrent	accounts 2021 → 2026	Accounts 2026 · 2026-00568687

Events

2026
Annual accounts 2026123,7 k €↑
2025
Annual accounts 2025-42,3 k €↑
21/03/2025
augmentation_capital
21/03/2025
reduction_capital
2024
Annual accounts 2024-1,2 M €↑
28/03/2023
augmentation_capital
20/01/2023
nominationJef Colruyt · administrateur
20/01/2023
nominationStefaan Vandamme · administrateur
20/01/2023
nominationJo Willemyns · administrateur
20/01/2023
nominationStefan Goethaert · administrateur
20/01/2023
nominationKris Castelein · administrateur
2022
Annual accounts 2022-2,4 M €↓
2021
Annual accounts 2021-726,8 k €↑
2020
Annual accounts 2020-2,1 M €↓
2019
Annual accounts 2019-874,7 k €↓
2018
Annual accounts 2018-418,3 k €
07/11/2017
IncorporationPublic limited company

NEWPHARMA GROUP

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events